Pathogenetic and Combined Treatment of Iron Deficiency Anemia with Drugs Increasing Erythropoiesis

dc.contributor.authorGulshanoi Akmaljonovna Karimkulova
dc.contributor.authorYuldasheva Nodira Ergashevna
dc.date.accessioned2026-01-02T11:32:59Z
dc.date.issued2023-05-13
dc.description.abstractAn increase in the amount of iron in the body leads to stimulation of the synthesis of hepcidin, which reduces iron absorption in the intestine, transport and circulation. In turn, a decrease in iron absorption in the intestine leads to inhibition of hepcidin synthesis in the liver and, in feedback, to the restoration of iron uptake from food and intestines. So far, antibodies against hepcidin have not been obtained and it is not possible to measure its level in a clinical setting. Work in this direction is underway.
dc.formatapplication/pdf
dc.identifier.urihttps://geniusjournals.org/index.php/emrp/article/view/4181
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/77592
dc.language.isoeng
dc.publisherGenius Journals
dc.relationhttps://geniusjournals.org/index.php/emrp/article/view/4181/3550
dc.sourceEurasian Medical Research Periodical; Vol. 20 (2023): EMRP; 98-100
dc.source2795-7624
dc.subjecthepcidin
dc.subjectiron amounts
dc.subjecttransport protein
dc.titlePathogenetic and Combined Treatment of Iron Deficiency Anemia with Drugs Increasing Erythropoiesis
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
karimkulova_2023_pathogenetic_and_combined_treatment_of_i.pdf
item.page.filesection.size
195.22 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections